#VisualAbstract: Cagrilintide-Semaglutide is Effective for Weight Loss in Adults with Overweight or Obesity and Type 2 Diabetes
Click here to read this study in NEJM. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Tag: type 2 diabetes
Oral semaglutide reduces cardiovascular event rates in high-risk patients
1. In this randomized controlled trial, oral semaglutide significantly reduced the risk of adverse cardiovascular events in patients with type ...
Spot capillary HbA1c testing may have a role in early detection of type 2 diabetes
1. In high-risk patients, point-of-care capillary HbA1c was superior to venous HbA1c as uptake was double, leading to faster results, ...
Automated insulin delivery improves glycemic control over continuous glucose monitoring
1. Among patients with type-2 diabetes (T2D) requiring insulin therapy, automated insulin delivery (AID) resulted in a greater reduction in ...
#VisualAbstract: Automated Insulin Delivery Effectively Reduces Blood Glucose Levels in Type 2 Diabetes
Click here to read this study in NEJM. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Weekly insulin efsitora noninferior to daily degludec in reducing glycated hemoglobin levels
1. In this randomized controlled trial, insulin alfa efsitora (efsitora) demonstrated noninferiority to degludec in reducing glycated hemoglobin (HbA1c) levels ...
#VisualAbstract: Insulin Efsitora is Noninferior to Degludec in Type 2 Diabetes without Previous Insulin Treatment
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Semaglutide reduces heart failure events in patients with preserved ejection fraction
1. Patients in the semaglutide group reported fewer heart failure events than those in the placebo group. 2. No significant ...
Early intensive glycemic control reduces long-term risk of death and myocardial infarction in patients with type 2 diabetes
1. Sulfonylurea, insulin therapy, and metformin resulted in a significant relative risk reduction for all-cause mortality and myocardial infarction. 2. ...
#VisualAbstract: Semaglutide Improves Outcomes in Patients with Type 2 Diabetes and Chronic Kidney Disease
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...